Stenosis of the external urethral orifice (SEE urethra) is a narrowing of the urethra in the area of the external orifice, which can lead to various urological dysfunctions. This condition can be the result of both congenital and acquired factors and, as a rule, manifests itself as difficulty urinating, pain syndrome, or a change in the nature of urination. These symptoms often become the reason for patients to seek medical help. The severity of stenosis can vary from a mild narrowing that partially obstructs the process of urination to a complete block requiring emergency intervention. Such a pathological process requires a comprehensive approach to diagnosis and treatment in order to minimize the risk of complications, such as urinary tract infections, bladder or kidney damage.
History of the disease and interesting historical facts
The history of urethral stenosis goes back several centuries. The first mentions of urethral diseases can be found in the works of ancient Greek and Roman physicians such as Hippocrates and Galen. In the Middle Ages, performing ureterotomy to eliminate stenosis was considered a rather risky procedure, and only in the 8th-10th centuries did safer surgical intervention methods begin to develop. Significant progress in the treatment of stenosis was achieved in the 19th century with the introduction of anesthesia and antiseptics, which made operations less traumatic and more predictable.
Epidemiology
Stenosis of the external urethral opening occurs in both men and women, but men are affected by this disease 3-5 times more often than women. Statistics show that urethral stenosis is diagnosed in 2-8% of all men seeking help in urology clinics. According to a study conducted in 2021, 20% men with this pathology experienced a relapse of stenosis after surgery.
Genetic predisposition to this disease
There are various genetic factors that can contribute to the development of urethral stenosis. Some studies indicate the involvement of certain genes, such as those responsible for the synthesis of collagen and other connective tissues. Mutations in the COL1A1 gene, which codes for type I collagen, can lead to abnormal formation of connective tissues in the urethra, increasing the risk of stenosis. In addition, genetic predisposition can combine with environmental and performance factors, which can ultimately provoke the occurrence of this pathology.
Risk factors for the development of this disease
Clinical studies have identified a number of risk factors that contribute to the development of stenosis of the external opening of the urethra:
- Trauma to the urethra or pelvic organs, including surgery
- Chronic inflammatory processes such as urethritis
- Processes associated with long-term catheterization
- Sexually transmitted diseases (STDs)
- Hereditary diseases of connective tissue.
Each of the listed factors can lead to a change in the structure of the back wall of the urethra, causing narrowing and disrupting normal urination.
Diagnosis of this disease
Diagnosis of stenosis of the external opening of the urethra includes several key elements:
- Main symptoms: Difficulty urinating, severe pain when urinating, feeling of incomplete emptying of the bladder.
- Laboratory tests: General urine analysis and bacteriological culture to identify infectious agents.
- Radiological examinations: Urethrography or ultrasound to determine the level and degree of narrowing.
- Other types of disease diagnostics: Cystoscopy for visual examination of the urethra and diagnosis of stenosis.
- Differential diagnosis: It is necessary to exclude other pathologies, such as urethral tumors or prostate adenoma.
Each of these studies is critical for correct diagnosis and appropriate treatment.
Treatment
Treatment for urethral orifice stenosis varies depending on the stage of the disease and the cause of its occurrence. The main approaches include:
- General treatment: Monitoring of patients with mild cases without significant symptoms.
- Pharmacological treatment: Use of antibiotics in the presence of infectious complications and anti-inflammatory drugs.
- Surgical treatment: Urethral dilation, urethrotomy or resection of narrowed areas.
- Other types of treatment: Use of stents to keep the urethra open.
A comprehensive approach to treatment sometimes requires a combination of methods, especially in more severe cases.
List of medications used to treat this disease
Common medications used to treat urethral stenosis include:
- Antibiotics: Ciprofloxacin, Amoxiclav
- Anti-inflammatory drugs: Ibuprofen, Diclofenac
- Local anesthetics for pain relief during diagnostic procedures
- Antispasmodics: Papaverine, Drotaverine
The choice of a specific drug depends on the individual characteristics of the patient and the stage of the disease.
Disease monitoring
Monitoring of urethral orifice stenosis involves several key steps:
- Control stages: Regular check-ups with a urologist, urine analysis for infection.
- Forecast: Successful treatment has a positive prognosis, but relapses are possible.
- Complications: Urinary tract infections, fistula formation, urethral perforation.
Planning follow-up care is important to identify potential complications early.
Age-related features of the disease
Stenosis of the external opening of the urethra can manifest itself differently depending on the patient's age group:
- Children: Usually congenital, often requires surgical intervention.
- Teenagers: May suffer from acquired stenosis, often as a result of injury.
- Adults: The ratio of acquired stenosis associated with inflammation and infection is most noticeable.
- Elderly: The presence of concomitant diseases is observed, which can aggravate the course of stenosis.
Thus, age characteristics play an important role in the choice of diagnostic and treatment methods.
Questions and Answers
- What are the main symptoms of urethral stenosis?
Answer: The main symptoms include difficulty urinating, pain and burning during urination, and a feeling of incomplete bladder emptying. - Can urethral stenosis be prevented?
Answer: Partially possible by avoiding injuries and infections, but congenital stenosis cannot be prevented. - How is stenosis of the external opening of the urethra treated?
Answer: Treatment may include observation, drug therapy, surgery, and stenting. - What is the chance of recurrence after stenosis treatment?
Answer: The risk of recurrence depends on the treatment method and individual patient characteristics, and ranges from 20% to 30% according to various data. - What complications can occur with stenosis?
Answer: Urinary tract infections, bladder damage and urethral perforation in extreme cases are possible.
Thus, stenosis of the external opening of the urethra is a serious medical problem that requires attention and a competent approach to diagnosis and treatment.
